A previous experimental study has shown that butyrate inhibits TNFα release and lipopolysaccharide (LPS)-induced IL-6 and IL-1β mRNA expression in the inflamed mucosa of adult CD patients via downregulation of the NF-κB pathway [83]. This evidence concerns the gene NFKB1 and Cowden disease.